Clinical study of rezvilutamide inhibiting the flare effect of GnRH agonists in the treatment of newly diagnosed metastatic prostate cancer.

被引：0
|
作者：
Wang, Shaogang
Wang, Zhihua
Hu, Zhiquan
Yang, Chunguang
机构：
[1] Huazhong Univ Sci & Technol, Wuhan, Peoples R China
[2] Huazhong Univ, Tongji Hosp, Tongji Med Coll, Urol Dept, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
3282-3221-3717; 261-566-9690; 3282-3221-2748-2527; 613-225-2575-2447; 283-2494-5577-5578; 261-436; 613-135-4642-282-153; 6; 5; 4; 2; 1917; 138; 73; 238; 3; 1; 38092-25779;
D O I：
10.1200/JCO.2024.42.4_suppl.TPS233
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：TPS233 / TPS233
页数：1
相关论文
共 50 条
  • [41] Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan
    Shintaro Narita
    Shingo Hatakeyama
    Masahiro Takahashi
    Toshihiko Sakurai
    Sadafumi Kawamura
    Senji Hoshi
    Masanori Ishida
    Toshiaki Kawaguchi
    Shigeto Ishidoya
    Jiro Shimoda
    Hiromi Sato
    Atsushi Koizumi
    Koji Mitsuzuka
    Tatsuo Tochigi
    Norihiko Tsuchiya
    Chikara Ohyama
    Yoichi Arai
    Kyoko Nomura
    Tomonori Habuchi
    International Journal of Clinical Oncology, 2020, 25 : 912 - 920
  • [42] Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan
    Narita, Shintaro
    Hatakeyama, Shingo
    Takahashi, Masahiro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Koizumi, Atsushi
    Mitsuzuka, Koji
    Tochigi, Tatsuo
    Tsuchiya, Norihiko
    Ohyama, Chikara
    Arai, Yoichi
    Nomura, Kyoko
    Habuchi, Tomonori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 912 - 920
  • [43] Prognostic value of anemia in newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894
    Beer, TM
    Tangen, CM
    Bland, LB
    Thompson, IM
    Crawford, ED
    JOURNAL OF UROLOGY, 2004, 172 (06): : 2213 - 2217
  • [44] A new model predicting survival in newly diagnosed hormone-sensitive metastatic prostate cancer: the utility of clinical and biochemical factors
    Tay, M.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 19 - 19
  • [45] A new model predicting survival in newly diagnosed hormone-sensitive metastatic prostate cancer: the utility of clinical and biochemical factors
    Gurbani, C.
    Tay, M.
    Chan, Y. H.
    Chiong, E.
    BJU INTERNATIONAL, 2019, 123 : 26 - 26
  • [46] Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A southwest oncology group study
    Hussain, M
    Fisher, EI
    Petrylak, DP
    O'Connor, J
    Wood, DP
    Small, EJ
    Eisenberger, MA
    Crawford, ED
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1043 - 1049
  • [47] CLINICAL STUDY TO IMPROVE PATIENT-HCP COMMUNICATION & ENGAGEMENT FOR NEWLY DIAGNOSED METASTATIC BREAST CANCER PATIENTS
    Beaumont, Corrine Ellsworth
    BREAST, 2017, 36 : S38 - S38
  • [48] Clinical utility of a 17-gene genomic prostate score (GPS) for treatment selection in men with newly diagnosed prostate cancer (PCa).
    Dall'Era, Marc A.
    Denes, Bela
    Lawrence, H. Jeffrey
    Tsiatis, Athanasios C.
    Rothney, Megan
    Maddala, Tara
    Febbo, Phillip G.
    Badani, Ketan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] Validation of a 3-gene signature and development of an authentic cohort database to improve overall survival prediction and clinical treatment decision for patients with newly diagnosed prostate cancer.
    Li, Chunde
    Peng, Zhuochun
    Andersson, Karl
    Lindholm, Johan
    Dethlefsen, Olga
    Pawitan, Yudi
    Nister, Monica
    Nilsson, Sten
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013)
    Weiner, Adam B.
    Matulewicz, Richard S.
    Tosoian, Jeffrey J.
    Feinglass, Joseph M.
    Schaeffer, Edward M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (03) : 91.e1 - 91.e6
12345